藥 物 回 收
|
| |
| Canada: Recall: Tepadina 100mg／vial Powder for Solution (English only) |
| |
Health Canada announces that Methapharm Inc. is recalling one lot of Tepadina (thiotepa) 100mg/vial Powder for Solution (lot number: 1709191/3) from wholesalers and healthcare establishments because vial seal and closure may be defective or loose in the affected lot.
Please refer to the following website in Health Canada for details:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../73053r-eng.php
In Hong Kong, Tepadina Powder for Concentrate For Solution For Infusion 100mg (HK-63411) is a pharmaceutical product registered by Hind Wing Co Ltd (Hind Wing), and is a prescription-only medicine. As confirmed with Hind Wing, the affected lot has not been imported into Hong Kong.
Ends/Tuesday, May 12, 2020
Issued at HKT 16:00
On 13 May 2020, the Department of Health (DH) endorsed Hind Wing Co Ltd to recall one batch (batch number: 1709191/2) of Tepadina Powder for Concentrate For Solution For Infusion 100mg (HK-63411) from the market as a precautionary measure due to a potential defect of the product. A press statement was issued on the same date. The DH will continue to monitor the recall.
Content last updated: Thursday, May 14, 2020
|
| |
